SCHEMBL4649434

SCHEMBL4649434

O=c1cc(-c2ccccc2)oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.66
MEN1 O00255 3/20 0.66
KMT2A Q03164 3/20 0.66
KDM4E B2RXH2 2/20 0.66
ALDH1A1 P00352 2/20 0.66
MAPT P10636 2/20 0.66
TDP1 Q9NUW8 2/20 0.66
HPGD P15428 1/20 0.66
CA12 O43570 4/20 0.63
CA9 Q16790 4/20 0.63
CA1 P00915 3/20 0.63
CA2 P00918 2/20 0.63
TNF P01375 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
SLCO2B1 O94956 1/20 0.62
IL2 P60568 3/20 0.57
RECQL P46063 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
NPC1 O15118 2/20 0.56
RAB9A P51151 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11304299 1.00 HSD17B10 (0.66) HSD17B10MEN1KMT2AKDM4EALDH1A1
SCHEMBL15387396 0.94 TNF (0.67) HSD17B10MEN1KMT2AKDM4EALDH1A1
SCHEMBL4650057 0.93 HSD17B10 (0.65) HSD17B10MEN1KMT2AKDM4EALDH1A1
SCHEMBL22568831 0.91 SMN1; SMN2 (0.75) HSD17B10MEN1KMT2AKDM4EALDH1A1
SCHEMBL16331082 0.90 SMN1; SMN2 (0.64) HSD17B10MEN1KMT2AKDM4EALDH1A1
SCHEMBL30266664 0.88 TNF (0.71) HSD17B10MEN1KMT2AKDM4EALDH1A1
SCHEMBL14430867 0.87 TNF (0.76) HSD17B10MEN1KMT2AKDM4EALDH1A1
SCHEMBL5199702 0.87 TNF (0.76) HSD17B10MEN1KMT2AKDM4EALDH1A1
SCHEMBL13052351 0.84 TNF (0.87) HSD17B10MEN1KMT2AKDM4EALDH1A1
SCHEMBL3453213 0.84 TNF (0.87) HSD17B10MEN1KMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US claimed
EP-2730431-B1 Rubber composition and tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2017-06-28 EP disclosed
US-20150056651-A1 MICROORGANISM PRODUCTION OF HIGH-VALUE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS OPX BIOTECHNOLOGIES INC (US) 2015-02-26 US disclosed
EP-2730431-A1 Rubber composition and tire with rubber containing flavone The Goodyear Tire & Rubber Company (US) 2014-05-14 EP disclosed
US-20130122541-A1 MICROORGANISM PRODUCTION OF HIGH-VALUE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS THE REGENTS OF THE UNIVERSITY OF COLORADO 2013-05-16 US disclosed
EP-1391327-B1 Tire with rubber containing flavone GOODYEAR TIRE & RUBBER (US) 2008-09-03 EP disclosed
US-6872771-B1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2005-03-29 US disclosed
EP-1391327-A1 Tire with rubber containing flavone THE GOODYEAR TIRE & RUBBER COMPANY (US) 2004-02-25 EP disclosed
WO-2003057210-A1 COMPOSITIONS AND METHODS FOR INCREASING CELL PROLIFERATION COMPRISING A FLAVONOID KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-07-17 WO disclosed
US-20030125264-A1 Methods For Treating Wounds KIMBERLY-CLARK WORLDWIDE, INC. 2003-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125264-A1 Methods For Treating Wounds FGF2, MMP1, FIBP HSD17B10 2250/4885MEN1 3867/4885KMT2A 4306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.